IP Library Assignment 039452/0156
Patent Assignment
Reel/Frame 039452/0156

Confirmatory License

Recorded: 2016-07-25 Pages: 2
Assignor
DANA-FARBER CANCER INST
Executed: 2016-07-21
Assignee
NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR), 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980, BETHESDA, MARYLAND, 20892-7980
Covered Property (1)
Combination Anti-Estrogen Receptor Cancer Therapy Using MUC1 Peptides and Chemotherapeutics
Patent: 9,572,855 →
Application: 14/774,163 →
Publication: US 2016/0058827
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 13, 2015
From: KUFE, DONALD W.
To: DANA-FARBER CANCER INSTITUTE, INC.
Reel/Frame 037029/0616 →
Assignment of Assignor's Interest Nov 13, 2015
From: KHARBANDA, SURENDER
To: GENUS ONCOLOGY, LLC
Reel/Frame 037029/0657 →